Triogen 250 mg
Triogen 250 mg is a medicine authorised by Swissmedic under authorisation number 67431. The authorisation holder is IDEOGEN AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 28 May 2020 and the authorisation is valid without a time limit. ATC code A16AX12 places the medicine in the group Other alimentary tract and metabolism products.
| Authorisation number | 67431 |
|---|---|
| Name | Triogen 250 mg |
| Full name | Triogen 250 mg, Kapseln |
| Authorisation holder | IDEOGEN AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A16AX12 |
| First authorisation | 28 May 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Triogen 250 mg, Kapseln | B | 28 May 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 100 | Kapsel(n) | A16AX12 | 07.99.0. | B |
| 2 | 30 | Kapsel(n) | A16AX12 | 07.99.0. | B |
| 3 | 72 | Kapsel(n) | A16AX12 | 07.99.0. | B |
| 4 | 96 | Kapsel(n) | A16AX12 | 07.99.0. | B |
| 5 | 240 | Kapsel(n) | A16AX12 | 07.99.0. | B |
| 6 | 300 | Kapsel(n) | A16AX12 | 07.99.0. | B |
| 7 | 100 | Kapsel(n) | A16AX12 | 07.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Triogen 250 mg authorised in Switzerland?
Yes. Triogen 250 mg is authorised by Swissmedic under authorisation number 67431, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Triogen 250 mg have?
Triogen 250 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Triogen 250 mg?
The authorisation holder is IDEOGEN AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.